| Application no. and date | 99901703.1 (espacenet) (Federated) (European Patent Register), 19990203 | | Patent/reg. no. and date | DK/EP 1052989, 20030730 | | Publication date | 20001122 | | Priority no. and date | FR 9801402, 19980206 | | EP pub. no. and date |
EP 1052989 20001122 | | Effective date | | | Applicant/owner | Aventis Pharma S.A., 20, avenue Raymond Aron
92160 Antony, FR | | Applicant ref. no. | 113391 | | Inventor | BOIREAU, Alain, 80, rue Porchefontaine
F-94370 Sucy en Brie, FR,
CANTON, Thierry, 1, avenue André Toutain
F-93270 Sevran, FR,
IMPERATO, Assunta, 195 bis, rue Raymond Losserand
F-75014 Paris, FR,
BOHME, Andrees, 32, rue Vitruve
F-75020 Paris, FR | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61P 21/00, A61P 25/14, A61K 31/425 | | Title | Anvendelse af 2-amino-6-trifluormethoxybenzothiazol til forebyggelse eller behandling af cerebellum-dysfunktion | | Int. application no. | FR1999000230 | | Int. publication no. | WO1999039710 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
